Campbell Deegan Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Sell
4,327
-294
-6% -$34.4K 0.39% 22
2026
Q1
$556K Sell
4,621
-2,210
-32% -$255K 0.44% 22
2025
Q4
$719K Buy
6,831
+1,325
+24% +$124K 0.58% 15
2025
Q3
$462K Hold
5,506
0.41% 21
2025
Q2
$436K Buy
5,506
+2
+0% +$159 0.43% 21
2025
Q1
$494K Sell
5,504
-409
-7% -$38.2K 0.57% 18
2024
Q4
$588K Buy
+5,913
New +$610K 0.71% 15

Other funds holding MRK

Campbell Deegan Wealth Management's MRK Position: Q2 2026 in Review

Campbell Deegan Wealth Management reduced its Merck (MRK) stake by 6.4% in Q2 2026, selling an estimated $34.4K and leaving 4,327 shares worth $556K. The position accounts for 0.39% of the portfolio, ranked #22.

Campbell Deegan Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $719K in Q4 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Campbell Deegan Wealth Management held 4,327 shares of Merck worth $556K as of Q2 2026.
  • Campbell Deegan Wealth Management sold 294 Merck shares in Q2 2026, an estimated $34.4K.
  • Merck made up 0.39% of Campbell Deegan Wealth Management's portfolio in Q2 2026, its #22 holding.
  • Campbell Deegan Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Campbell Deegan Wealth Management's Merck position peaked at $719K in Q4 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Campbell Deegan Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.